Early molecular and genetic determinants of primary liver malignancy.
about
Expression of aspartyl beta-hydroxylase and its clinicopathological significance in hepatocellular carcinomaMAK-4 and -5 supplemented diet inhibits liver carcinogenesis in mice.Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United StatesHost susceptibility to persistent hepatitis B virus infectionEGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation.Gene expression profile related to the progression of preneoplastic nodules toward hepatocellular carcinoma in rats.Analysis of gene expression profiles as a tool to uncover tumor markers of liver cancer progression in a rat model.Targeted therapy in hepatocellular carcinomaScience to practice: what do molecular biologic studies in rodent models add to our understanding of interventional oncologic procedures including percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists?Single nucleotide polymorphism profiling assay to confirm the identity of human tissues.A novel antihepatitis drug, bicyclol, prevents liver carcinogenesis in diethylnitrosamine-initiated and phenobarbital-promoted mice tumor model.Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.p53 gene in treatment of hepatic carcinoma: status quo.Characteristic gene expression profiles in the progression from liver cirrhosis to carcinoma induced by diethylnitrosamine in a rat model.Liver development and cancer formation in zebrafish.The molecular pathogenesis and clinical implications of hepatocellular carcinoma.HBx-dependent cell cycle deregulation involves interaction with cyclin E/A-cdk2 complex and destabilization of p27Kip1.Chemopreventive effect of dimethyl dicarboxylate biphenyl on malignant transformation of WB-F344 rat liver epithelial cells.Systemic Treatment of Patients with Advanced, Unresectable Hepatocellular Carcinoma: Emergence of Therapies.
P2860
Q28286169-CEE8C405-D63B-41B3-BB48-F09B2773A3B9Q33287215-382B0BF5-3620-4B63-8791-E23D64A58A4BQ33788058-0793C035-B038-41B1-B6DE-376E2C21D3ECQ33866976-54193945-FC5B-4227-A943-DDDFDA62D1D6Q34282375-D7223191-C8C9-46BD-A800-8D8C65F6D8C1Q35070081-4A00DD7A-3563-488D-9AF1-2B67FD1C58D6Q35180104-B78C4533-5936-48D5-830B-3EEBB4082CFAQ35207561-2E860A8A-FF85-4B06-BFEB-FEA9E75BDED5Q35773556-6C2F22BF-E405-447E-8366-723C5B1CD143Q35789593-E2222CCB-D714-4329-A2F8-4579DB8146D7Q35830230-B60CEA06-064F-4378-9726-99EC8018B657Q36561669-7CD3966B-5610-4DC2-B631-475730BC0413Q36764842-D9AD63A1-E3BE-4D73-A538-552721EBF52CQ37311536-356171CF-29A1-4FD6-BD44-1F522A7A829CQ37889223-51FF7860-D881-4FB4-B264-E3493E9CB764Q37970351-A49588D0-4C0C-481C-BA46-57F60806CB12Q38310248-857A0BB3-4872-4AA2-8999-637ADD1781C3Q46753477-C08C03EA-500C-4664-85B1-4C0300561FDCQ49907735-23F89F68-6B38-446C-BBFB-C58CF05352BE
P2860
Early molecular and genetic determinants of primary liver malignancy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Early molecular and genetic determinants of primary liver malignancy.
@ast
Early molecular and genetic determinants of primary liver malignancy.
@en
type
label
Early molecular and genetic determinants of primary liver malignancy.
@ast
Early molecular and genetic determinants of primary liver malignancy.
@en
prefLabel
Early molecular and genetic determinants of primary liver malignancy.
@ast
Early molecular and genetic determinants of primary liver malignancy.
@en
P2093
P1476
Early molecular and genetic determinants of primary liver malignancy.
@en
P2093
Jingbo Pan
Mark A Feitelson
Zhaorui Lian
P304
P356
10.1016/S0039-6109(03)00226-3
P577
2004-04-01T00:00:00Z